Cargando…
Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer
BACKGROUND: Targeting the type 1 insulin-like growth factor receptor (IGF1R) in breast cancer remains an ongoing clinical challenge. Oncogenic IGF1R-signaling occurs via activation of PI3K/AKT/MAPK downstream mediators which regulate cell proliferation and protein synthesis. To further understand IG...
Autores principales: | Ochnik, Aleksandra M., Baxter, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718000/ https://www.ncbi.nlm.nih.gov/pubmed/29207959 http://dx.doi.org/10.1186/s12885-017-3809-0 |
Ejemplares similares
-
Sphingosine kinase/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation
por: Bernacchioni, Caterina, et al.
Publicado: (2012) -
Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015) -
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
por: Kim, Hyun-Soo, et al.
Publicado: (2015) -
Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer
por: Zhang, Xihong, et al.
Publicado: (2000) -
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
por: Hamilton, Nalo, et al.
Publicado: (2017)